Biphasic Insulin Aspart 30 in Type 2 Diabetes Failing OAD Therapy
Status:
Completed
Trial end date:
2004-03-01
Target enrollment:
Participant gender:
Summary
This trial is conducted in the United States of America (USA). The aim of this trial is to
compare biphasic insulin aspart 30 plus metformin in a standard injection regimen to a
standard dosing of insulin glargine plus metformin on blood glucose control in subjects with
type 2 diabetes who are insulin naive and failing OAD therapy.